| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |